Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.54 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.53 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.47 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.47 |
| ▸ | ITGB2 | P05107 | 3/20 | 0.44 |
| ▸ | ICAM1 | P05362 | 3/20 | 0.44 |
| ▸ | ITGAL | P20701 | 3/20 | 0.44 |
| ▸ | REN | P00797 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16819885 | 1.00 | SLC15A2 (0.54) | SLC15A2SLC6A5EPHX2CPB2ITGB2 | |
| SCHEMBL16819850 | 0.95 | SLC15A2 (0.52) | SLC15A2SLC6A5EPHX2CPB2ITGB2 | |
| SCHEMBL16819854 | 0.95 | SLC15A2 (0.52) | SLC15A2SLC6A5EPHX2CPB2ITGB2 | |
| SCHEMBL16819866 | 0.92 | SLC15A2 (0.47) | SLC15A2SLC6A5EPHX2CPB2ITGB2 | |
| SCHEMBL15426895 | 0.92 | SLC15A2 (0.47) | SLC15A2SLC6A5EPHX2CPB2ITGB2 | |
| SCHEMBL15426894 | 0.90 | SLC15A2 (0.46) | SLC15A2SLC6A5EPHX2CPB2REN | |
| SCHEMBL16819849 | 0.90 | SLC15A2 (0.46) | SLC15A2SLC6A5EPHX2CPB2REN | |
| SCHEMBL15426898 | 0.89 | SLC15A2 (0.55) | SLC15A2SLC6A5EPHX2CPB2ITGB2 | |
| SCHEMBL16819851 | 0.89 | SLC15A2 (0.55) | SLC15A2SLC6A5EPHX2CPB2ITGB2 | |
| SCHEMBL20384898 | 0.88 | EPHX2 (0.49) | SLC15A2SLC6A5EPHX2ITGB2ICAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10028935-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2018-07-24 | — | — | US | claimed |
| US-20170135986-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS, LLC | 2017-05-18 | — | — | US | claimed |
| US-9382211-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2016-07-05 | — | — | US | claimed |
| US-20150175552-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS, LLC | 2015-06-25 | — | — | US | claimed |
| US-10028935-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2018-07-24 | — | — | US | disclosed |
| US-10028935-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2018-07-24 | — | — | US | disclosed |
| US-20170135986-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS, LLC | 2017-05-18 | — | — | US | disclosed |
| US-20170135986-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS, LLC | 2017-05-18 | — | — | US | disclosed |
| US-9593079-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2017-03-14 | — | — | US | disclosed |
| US-9593079-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2017-03-14 | — | — | US | disclosed |
| US-9382211-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2016-07-05 | — | — | US | disclosed |
| US-9382211-B2 | Stabilized multi-functional antioxidant compounds and methods of use | XPD HOLDINGS, LLC (US) | 2016-07-05 | — | — | US | disclosed |
| US-20160185718-A1 | Stabilized Multi-Functional Antioxidant Compounds and Methods of Use | XPD HOLDINGS, LLC | 2016-06-30 | — | — | US | disclosed |
| US-20160185718-A1 | Stabilized Multi-Functional Antioxidant Compounds and Methods of Use | XPD HOLDINGS, LLC | 2016-06-30 | — | — | US | disclosed |
| US-20150175552-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS, LLC | 2015-06-25 | — | — | US | disclosed |
| US-20150175552-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS, LLC | 2015-06-25 | — | — | US | disclosed |
| WO-2014011624-A2 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | XPD HOLDINGS LLC (US) | 2014-01-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10028935-B2 | Stabilized multi-functional antioxidant compounds and methods of use | SOD1, GPX4, SOD3 | SLC15A2 2163/4885SLC6A5 3930/4885EPHX2 3420/4885 |
| US-20150175552-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | SOD1, GPX4, SOD3 | SLC15A2 2163/4885SLC6A5 3930/4885EPHX2 3420/4885 |
| US-20170135986-A1 | STABILIZED MULTI-FUNCTIONAL ANTIOXIDANT COMPOUNDS AND METHODS OF USE | SOD1, GPX4, SOD3 | SLC15A2 2163/4885SLC6A5 3930/4885EPHX2 3420/4885 |
| US-20160185718-A1 | Stabilized Multi-Functional Antioxidant Compounds and Methods of Use | SOD1, GPX4, SOD3 | SLC15A2 2163/4885SLC6A5 3930/4885EPHX2 3420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.